Lancet Infect Dis

ISSN	1474-4457
ISSN-L	-
IUID	d45ff4f5fbbe4892ab8df680e967a50d
Modified	2020-12-01T17:16:03.860Z
Created	2020-12-01T17:16:03.860Z

Year 2025

PubMed DOI Crossref

Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trial.

Haidar G, Thomas S, Loubet P, ..., Cohen TS, SUPERNOVA study group

Lancet Infect Dis - (-) - [2025-02-24; online 2025-02-24]

Category: Health Category: Vaccines Type: Journal article

PubMed DOI Crossref

Targeting the SARS-CoV-2 reservoir in long COVID.

Proal AD, Aleman S, Bomsel M, ..., Yonker LM, Peluso MJ

Lancet Infect Dis - (-) - [2025-02-10; online 2025-02-10]

Category: Post-COVID Type: Journal article

Year 2024

PubMed DOI Crossref

Relative vaccine protection, disease severity, and symptoms associated with the SARS-CoV-2 omicron subvariant BA.2.86 and descendant JN.1 in Denmark: a nationwide observational study.

Moustsen-Helms IR, Bager P, Larsen TG, ..., Hansen CH, SSI-DMC Study Group

Lancet Infect Dis - (-) - [2024-05-15; online 2024-05-15]

Category: Omicron VoC Category: Vaccines Type: Journal article

Year 2023

PubMed DOI Crossref

Neutralisation activity of mucosal IgA against XBB sublineages and BA.2.86.

Zuo F, Cao Y, Sun R, ..., Marcotte H, Pan-Hammarström Q

Lancet Infect Dis - (-) - [2023-12-07; online 2023-12-07]

Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Funder: VR Type: Journal article

PubMed DOI Crossref

Sensitivity of the SARS-CoV-2 BA.2.86 variant to prevailing neutralising antibody responses.

Sheward DJ, Yang Y, Westerberg M, ..., Albert J, Murrell B

Lancet Infect Dis 23 (11) e462-e463 [2023-11-00; online 2023-09-27]

Category: Biochemistry Category: Genomics & transcriptomics Category: Health Funder: KAW/SciLifeLab National COVID program Type: Journal article

PubMed DOI Crossref

Blom K, Fjällström P, Molnár C, ..., Forsell MNE, Johansson AF

Lancet Infect Dis - (-) - [2023-09-13; online 2023-09-13]

Category: Biochemistry Category: Health Category: Public Health Type: Journal article

PubMed DOI Crossref

Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a retrospective matched cohort study.

Mateo-Urdiales A, Sacco C, Fotakis EA, ..., Pezzotti P, Fabiani M

Lancet Infect Dis - (-) - [2023-07-18; online 2023-07-18]

Category: Vaccines Type: Journal article

Year 2022

PubMed DOI Crossref

Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection.

Blom K, Marking U, Havervall S, ..., Klingström J, Thålin C

Lancet Infect Dis 22 (7) 943-945 [2022-07-00; online 2022-06-09] Open Access

Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Research Area: Biobanks for COVID-19 research Type: Journal article

PubMed DOI Crossref

Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study.

Sheward DJ, Kim C, Ehling RA, ..., Albert J, Murrell B

Lancet Infect Dis 22 (6) 813-820 [2022-06-00; online 2022-03-17] Open Access

Category: Biochemistry Category: Health Category: Omicron VoC Type: Journal article

PubMed DOI Crossref

Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden.

Nordström P, Ballin M, Nordström A

Lancet Infect Dis 22 (6) 781-790 [2022-06-00; online 2022-04-01]

Category: Health Category: Public Health Type: Journal article

Year 2021

PubMed DOI Crossref

Testing indicators to monitor the COVID-19 pandemic.

Beauté J, Adlhoch C, Bundle N, Melidou A, Spiteri G

Lancet Infect Dis - (-) - [2021-08-24; online 2021-08-24]

Type: Other

PubMed DOI Crossref

Persistence of IgG response to SARS-CoV-2.

Duysburgh E, Mortgat L, Barbezange C, ..., Ariën KK, Desombere I

Lancet Infect Dis 21 (2) 163-164 [2021-02-00; online 2020-12-17]

Type: Other

Year 2020

PubMed DOI Crossref

Beyond COVID-19-a paradigm shift in infection management?

Vehreschild MJGT, Tacconelli E, Giske CG, Peschel A

Lancet Infect Dis - (-) - [2020-10-09; online 2020-10-09]

Type: Other

PubMed DOI Crossref

Long-term consequences of COVID-19: research needs.

Yelin D, Wirtheim E, Vetter P, ..., Kaiser L, Leibovici L

Lancet Infect Dis 20 (10) 1115-1117 [2020-10-00; online 2020-09-01]

Type: Other

PubMed DOI Crossref

Estimation of COVID-19 burden in Egypt - Authors' reply.

Tuite AR, Ng V, Rees E, ..., Khan K, Bogoch II

Lancet Infect Dis 20 (8) 897-898 [2020-08-00; online 2020-04-27]

Type: Other

PubMed DOI Crossref

Estimation of the COVID-19 burden in Egypt through exported case detection.

Tuite AR, Ng V, Rees E, ..., Khan K, Bogoch II

Lancet Infect Dis 20 (8) 894 [2020-08-00; online 2020-03-26]

Type: Other